Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Assets Average (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Assets Average for 4 consecutive years, with $25.5 million as the latest value for Q3 2020.

  • On a quarterly basis, Assets Average fell 67.28% to $25.5 million in Q3 2020 year-over-year; TTM through Sep 2020 was $25.5 million, a 67.28% decrease, with the full-year FY2019 number at $55.4 million, down 43.26% from a year prior.
  • Assets Average was $25.5 million for Q3 2020 at Forte Biosciences, up from $23.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $106.5 million in Q3 2017 to a low of $13.1 million in Q1 2020.
  • A 4-year average of $68.9 million and a median of $83.0 million in 2018 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 145.26% in 2018, then crashed 86.71% in 2020.
  • Forte Biosciences' Assets Average stood at $97.1 million in 2017, then dropped by 0.42% to $96.7 million in 2018, then tumbled by 59.47% to $39.2 million in 2019, then plummeted by 34.9% to $25.5 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Assets Average are $25.5 million (Q3 2020), $23.5 million (Q2 2020), and $13.1 million (Q1 2020).